- CA$1.16bn
- CA$2.35bn
- CA$360.52m
Annual income statement for Dividend 15 Split, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.
2021 November 30th | 2022 November 30th | 2023 November 30th | 2024 November 30th | 2025 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 247 | 75.5 | -22 | 484 | 361 |
| Cost of Revenue | |||||
| Gross Profit | 234 | 61 | -36.4 | 469 | 343 |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 15.5 | 16.6 | 16.4 | 17.8 | 20.3 |
| Operating Profit | 232 | 58.9 | -38.5 | 467 | 340 |
| Net Income Before Taxes | 232 | 58.9 | -38.5 | 467 | 340 |
| Net Income After Taxes | 232 | 58.9 | -38.5 | 467 | 340 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 232 | 58.9 | -38.5 | 467 | 340 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 184 | -1.7 | -114 | 399 | 258 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.47 | -0.017 | -0.977 | 3.26 | 1.9 |
| Dividends per Share |